|Minimum Order Quantity||500 Number|
|Usage|| Clinical, Hospital, Commercial|
|Uses|| Skin Problems|
|Packaging Size||15 gm|
|Area Of Application||skin|
|Packing Size||15 g|
|Type Of Skin Ointment||Biological Products|
Onychomycosis is a common fungal infection caused by dermatophytes, non-dermatophytes, and yeasts. This superficial fungal infection has been successfully managed with topical and oral antimycotics. Although current treatments with the oral antifungals, terbinafine, itraconazole, fluconazole, and the topical nail lacquers, ciclopirox and amorolfine have greatly improved treatment efficacy there are still reports of failure. In addition, some cases of onychomycosis, such as severe onychomycosis, lateral nail involvement, spike, or dermatophytoma, may require a combination of therapies for successful management. Combination therapies, compared to monotherapy with an oral or topical antifungal agent alone, may provide a broad spectrum of coverage and allow for shorter duration of therapy. Additionally, a combination of therapies may be more cost-effective. A single-blind, randomized controlled study is currently underway to evaluate the efficacy and safety of combination therapy compared to monotherapy using oral antifungals in the treatment of dermatophyte toenail onychomycosis.